Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.

Hsu, Janet

Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society Feb 2011 - 323-31 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1873-4995

10.1016/j.jconrel.2010.10.031 doi


Animals
Antibodies, Monoclonal--chemistry
Antigens, Tumor-Associated, Carbohydrate--metabolism
Cell Line
Drug Carriers--chemistry
Endothelial Cells--immunology
Endothelium, Vascular--cytology
Enzyme Replacement Therapy
Fabry Disease--drug therapy
Humans
Intercellular Adhesion Molecule-1--immunology
Lysosomes--metabolism
Mice
Mice, Inbred C57BL
alpha-Galactosidase--administration & dosage